Therapeutic efficacy of TBC3711 in monocrotaline-induced pulmonary hypertension (Q21284417)

inferred from title

pulmonary hypertension

1 reference

13

Werner Seeger

Werner

Seeger

1 reference

20 August 2022

Akylbek Sydykov

5

Akylbek

Sydykov

1 reference

20 August 2022

Ralph T Schermuly

14

Ralph T

Schermuly

1 reference

20 August 2022

Norbert Weissmann

11

Norbert

Weissmann

1 reference

20 August 2022

Friedrich Grimminger

12

Friedrich

Grimminger

1 reference

20 August 2022

Ralf P Brandes

8

Ralf P

Brandes

1 reference

20 August 2022

2

Baktybek Kojonazarov

Baktybek

Kojonazarov

1 reference

20 August 2022

10

Hossein A

Ghofrani

Hossein A Ghofrani

1 reference

20 August 2022

6

Teodora

Cornitescu

Teodora Cornitescu

1 reference

20 August 2022

1

Djuro

Kosanovic

Djuro Kosanovic

1 reference

20 August 2022

4

Bhola K

Dahal

Bhola K Dahal

1 reference

20 August 2022

3

Himal

Luitel

Himal Luitel

1 reference

20 August 2022

9

Neil

Davie

Neil Davie

1 reference

20 August 2022

Wiebke Janssen

7

Wiebke

Janssen

1 reference

1010011084

Therapeutic efficacy of azaindole-1 in experimental pulmonary hypertension

20 August 2022

language of work or name

English

0 references

publication date

2011

0 references

published in

Respiratory Research

0 references

volume

12

0 references

issue

1

0 references

page(s)

87

0 references

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3141422

Curcumin prevents and reverses murine cardiac hypertrophy

19 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3141422

A novel potent vasoconstrictor peptide produced by vascular endothelial cells

19 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3141422

Role for miR-204 in human pulmonary arterial hypertension

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3141422

Future perspectives for the treatment of pulmonary arterial hypertension

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3141422

Endothelin receptor antagonists in preclinical models of pulmonary hypertension

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3141422

Therapeutic advances in pulmonary arterial hypertension.

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3141422

Echocardiography in the assessment of right heart function

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3141422

Dual ET(A)/ET(B) vs. selective ET(A) endothelin receptor antagonism in patients with pulmonary hypertension

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3141422

Reversal of experimental pulmonary hypertension by PDGF inhibition

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3141422

Development of occlusive neointimal lesions in distal pulmonary arteries of endothelin B receptor-deficient rats: a new model of severe pulmonary arterial hypertension

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3141422

Cellular and molecular pathobiology of pulmonary arterial hypertension

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3141422

Endothelial dysfunction in pulmonary hypertension

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3141422

The pathobiology of pulmonary hypertension. Endothelium

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3141422

Human endothelin receptors characterized using reverse transcriptase-polymerase chain reaction, in situ hybridization, and subtype-selective ligands BQ123 and BQ3020: evidence for expression of ETB receptors in human vascular smooth muscle.

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3141422

TBC3711, an ET(A) receptor antagonist, reduces neonatal hypoxia-induced pulmonary hypertension in piglets

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3141422

Pulmonary clearance of circulating endothelin-1 in dogs in vivo: exclusive role of ETB receptors

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3141422

Endothelin peptides: biological actions and pathophysiological significance in the lung

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3141422

Endothelin receptor subtype B mediates synthesis of nitric oxide by cultured bovine endothelial cells

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3141422

BQ123, an ETA-receptor antagonist, attenuates hypoxic pulmonary hypertension in rats.

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3141422

ETA-receptor antagonist prevents and reverses chronic hypoxia-induced pulmonary hypertension in rat.

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3141422

Comparison of three Doppler ultrasound methods in the prediction of pulmonary artery pressure

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3141422

Increased plasma endothelin-1 in pulmonary hypertension: marker or mediator of disease?

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3141422

Both ETA and ETB receptors mediate contraction to endothelin-1 in human blood vessels.

30 May 2018

1 reference

https://api.crossref.org/works/10.1186%2F1465-9921-12-87

Roles of endothelin ETA and ETB receptors in the pathogenesis of monocrotaline-induced pulmonary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1465-9921-12-87

Activation of the right ventricular endothelin (ET) system in the monocrotaline model of pulmonary hypertension: response to chronic ETA receptor blockade.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1465-9921-12-87

Endothelin-1 and right-sided heart failure in rats: effects of an endothelin receptor antagonist on the failing right ventricle

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1465-9921-12-87

The orally active nonpeptide selective endothelin ETA receptor antagonist YM598 prevents and reverses the development of pulmonary hypertension in monocrotaline-treated rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1465-9921-12-87

Inhibition of endothelin-1 and hypoxia-induced pulmonary pressor responses in the rat by a novel selective endothelin-A receptor antagonist, di-n-butylaminocarbamyl-L-leucyl-D-tryptophanyl-D-4-chloro-Phe

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1465-9921-12-87

Discovery, modeling, and human pharmacokinetics of N-(2-acetyl-4,6-dimethylphenyl)-3-(3,4-dimethylisoxazol-5-ylsulfamoyl)thiophene-2-carboxamide (TBC3711), a second generation, ETA selective, and orally bioavailable endothelin antagonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1465-9921-12-87

Endothelin A receptor blockade improves regression of flow-induced pulmonary vasculopathy in piglets

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1465-9921-12-87

Echocardiographic measurement of cardiac output in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1465-9921-12-87

Role of epidermal growth factor inhibition in experimental pulmonary hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1465-9921-12-87

Computerized image analysis of Sirius Red-stained renal allograft biopsies as a surrogate marker to predict long-term allograft function

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1465-9921-12-87

STRIDE 1: effects of the selective ET(A) receptor antagonist, sitaxsentan sodium, in a patient population with pulmonary arterial hypertension that meets traditional inclusion criteria of previous pulmonary arterial hypertension trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1465-9921-12-87

Doppler tissue imaging in assessment of pulmonary hypertension-induced right ventricle dysfunction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1465-9921-12-87

A novel orally active endothelin-A receptor antagonist, ZD1611, prevents chronic hypoxia-induced pulmonary hypertension in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1465-9921-12-87

Signal transducers and activators of transcription-3/pim1 axis plays a critical role in the pathogenesis of human pulmonary arterial hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1465-9921-12-87

Bosentan, sildenafil, and their combination in the monocrotaline model of pulmonary hypertension in rats.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3141422

Endothelin-1 is elevated in monocrotaline pulmonary hypertension.

29 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3141422

Inhibition of myocardial endothelin pathway improves long-term survival in heart failure

29 November 2018

1 reference

https://api.crossref.org/works/10.1186%2F1465-9921-12-87

Defective Intracellular Calcium Handling in Monocrotaline-Induced Right Ventricular Hypertrophy: Protective Effect of Long-Term Endothelin-A Receptor Blockade with 2-Benzo[1,3]dioxol-5-yl-3-benzyl-4-(4-methoxy-phenyl-)- 4-oxobut-2-enoate-sodium (PD 1

21 January 2018

1 reference

12 December 2020

Sitaxsentan for the prevention of experimental shunt-induced pulmonary hypertension

1 reference

12 December 2020

Pulmonary arterial hypertension

1 reference

12 December 2020

Chronic hypoxia induces nonreversible right ventricle dysfunction and dysplasia in rats

1 reference

12 December 2020

Endothelin-1 induces hypertrophy with enhanced expression of muscle-specific genes in cultured neonatal rat cardiomyocytes

1 reference

12 December 2020

Contribution of endogenous endothelin-1 to the progression of cardiopulmonary alterations in rats with monocrotaline-induced pulmonary hypertension

1 reference

12 December 2020

Endothelin-receptor antagonist bosentan prevents and reverses hypoxic pulmonary hypertension in rats

1 reference

12 December 2020

The Orally Active Nonpeptide Endothelin A-Receptor Antagonist A-127722 Prevents and Reverses Hypoxia-Induced Pulmonary Hypertension and Pulmonary Vascular Remodeling in Sprague-Dawley Rats

1 reference

12 December 2020

The orally active ET(A) receptor antagonist (+)-(S)-2-(4,6-dimethoxy-pyrimidin-2-yloxy)-3-methoxy-3,3-diphe nyl-propionic acid (LU 135252) prevents the development of pulmonary hypertension and endothelial metabolic dysfunction in monocrotaline-trea

1 reference

12 December 2020

Expression of endothelin-1, ETA and ETB receptors, and ECE and distribution of endothelin-1 in failing rat heart

1 reference

12 December 2020

Sequence of echocardiographic changes during development of right ventricular failure in rat

1 reference

12 December 2020

Endothelial cell dysfunction correlates differentially with survival in primary and secondary pulmonary hypertension

1 reference

12 December 2020

Attenuation of pulmonary vascular hypertension and cardiac hypertrophy with sitaxsentan sodium, an orally active ET(A) receptor antagonist

1 reference

12 December 2020

Effect of stretch on contraction and the Ca2+ transient in ferret ventricular muscles during hypoxia and acidosis

1 reference

https://api.crossref.org/works/10.1186%2F1465-9921-12-87

7 January 2021

inferred from DOI database lookup

Dopamine 5 receptor mediates Ang II type 1 receptor degradation via a ubiquitin-proteasome pathway in mice and human cells

1 reference

https://api.crossref.org/works/10.1186%2F1465-9921-12-87

7 January 2021

inferred from DOI database lookup

Identifiers

DOI

10.1186/1465-9921-12-87

0 references